Culture Biosciences
YC W18 ↗San Francisco, US · 40 employees · 11 known investors
Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.
AI & Machine LearningBiotechCloud ComputingHealthtechCellular Agriculturein /culture-robotics/@culturebiosciycombinator.com ↗
Founders & leadership· Y Combinator alumni (W18)
WP
Will PatrickinFounder/CEO
Investors · 11
CompoundNew York · $400K – $1.5M
DCVC (Data Collective)Palo Alto · $5M – $25M
E14 FundCambridge · $1M – $5M
Hemisphere Ventures LLC
The E14 FundCambridge · $1M – $5M
Y CombinatorSan Francisco · $500K
Craft VenturesreportedSan Francisco · $50K – $50M
Cultivian Sandbox VenturesreportedChicago · $5M – $15M
Northpond VenturesreportedBethesda · $100K – $5M
S32reportedPalo Alto
Synthesis CapitalreportedLondon
In the news
- Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platformculturebiosciences.com · 2025
- Culture Biosciences Closes Series C Fundingfinsmes.com · 2025
- Culture Biosciences raises $80 millioncen.acs.org · 2021
- Why Investors Just Poured $80M Into This Startup’s Cloud Bioreactor Platformgreenqueen.com.hk · 2021
- Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturingbusinesswire.com · 2021
- Culture Biosciences Raises $80M in Series B Fundingfinsmes.com · 2021
- Culture Biosciences Raises $5.5M in Funding - FinSMEsfinsmes.com · 2019